INTRODUCTION: Androgen deprivation therapy (ADT) is an important component of modern prostate cancer treatment. Survival benefits from neo-adjuvant and adjuvant hormones may take years to manifest, and balancing this with potential morbidity of therapy can be challenging. This study aimed to assess whether education and short-term combined aerobic and resistance exercises could help to ameliorate the adverse side effects of ADT. METHODS: Eight hundred fifty-nine patients with relapsed or metastatic prostate cancer on leuprorelin acetate were allocated to three interventional streams based on patient preference and medical fitness: supervised group (Face-to-Face) exercise sessions, home-based (At Home) exercise or a support programme for those incapable of exercising (Support). Patients enrolled onto Face to Face underwent measurement of body composition and cardiorespiratory fitness variables at baseline and programme completion. Patients in the exercise streams were surveyed to determine the programme's impact on physical fitness and well-being. RESULTS: Statistically significant improvements (p < 0.001) were seen in all measured cardiorespiratory fitness and strength variables. Programme attrition rates were low (75/859; 8.7%), the primary reason for withdrawal being discontinuation of hormones (70%). Programme satisfaction was high, with 98% of surveyed patients reporting a positive impact on fitness and 97% planning to continue exercising after programme completion. At 6 months, improved physical and emotional well-being was reported by 93 and 79% of patients, respectively. CONCLUSIONS: A short-term structured exercise intervention results in high compliance and significant improvements in muscle strength and cardiorespiratory fitness in prostate cancer patients on ADT.
INTRODUCTION: Androgen deprivation therapy (ADT) is an important component of modern prostate cancer treatment. Survival benefits from neo-adjuvant and adjuvant hormones may take years to manifest, and balancing this with potential morbidity of therapy can be challenging. This study aimed to assess whether education and short-term combined aerobic and resistance exercises could help to ameliorate the adverse side effects of ADT. METHODS: Eight hundred fifty-nine patients with relapsed or metastatic prostate cancer on leuprorelin acetate were allocated to three interventional streams based on patient preference and medical fitness: supervised group (Face-to-Face) exercise sessions, home-based (At Home) exercise or a support programme for those incapable of exercising (Support). Patients enrolled onto Face to Face underwent measurement of body composition and cardiorespiratory fitness variables at baseline and programme completion. Patients in the exercise streams were surveyed to determine the programme's impact on physical fitness and well-being. RESULTS: Statistically significant improvements (p < 0.001) were seen in all measured cardiorespiratory fitness and strength variables. Programme attrition rates were low (75/859; 8.7%), the primary reason for withdrawal being discontinuation of hormones (70%). Programme satisfaction was high, with 98% of surveyed patients reporting a positive impact on fitness and 97% planning to continue exercising after programme completion. At 6 months, improved physical and emotional well-being was reported by 93 and 79% of patients, respectively. CONCLUSIONS: A short-term structured exercise intervention results in high compliance and significant improvements in muscle strength and cardiorespiratory fitness in prostate cancerpatients on ADT.
Authors: T Hasenoehrl; M Keilani; T Sedghi Komanadj; M Mickel; M Margreiter; M Marhold; R Crevenna Journal: Support Care Cancer Date: 2015-05-24 Impact factor: 3.603
Authors: Nicolas H Hart; Robert U Newton; Nigel A Spry; Dennis R Taaffe; Suzanne K Chambers; Kynan T Feeney; David J Joseph; Andrew D Redfern; Tom Ferguson; Daniel A Galvão Journal: BMJ Open Date: 2017-05-30 Impact factor: 2.692
Authors: Daniel A Galvão; Dickon Hayne; Mark Frydenberg; Suzanne K Chambers; Dennis R Taaffe; Nigel Spry; Paul A Scuffham; Robert S Ware; Nicolas H Hart; Robert U Newton Journal: BMJ Open Date: 2018-04-20 Impact factor: 2.692
Authors: S Sattar; K R Haase; C Bradley; E Papadopoulos; S Kuster; D Santa Mina; M Tippe; A Kaur; D Campbell; A M Joshua; C Rediger; O Souied; S Alibhai Journal: Prostate Cancer Prostatic Dis Date: 2021-06-09 Impact factor: 5.455
Authors: Natalia S Zabegalina; Michaël M E L Henderickx; Veerle Lamotte; Bart Segers; Gaetane Stassijns; Stefan De Wachter; Lucien Hoekx Journal: Cent European J Urol Date: 2018-06-12